ICU Medical Inc. (ICUI)

290.88
3.80 1.30
NASDAQ : Health Technology
Prev Close 294.65
Open 296.30
Day Low/High 289.00 / 299.40
52 Wk Low/High 164.00 / 313.20
Volume 239.50K
Avg Volume 114.00K
Exchange NASDAQ
Shares Outstanding 20.32M
Market Cap 6.09B
EPS 3.50
P/E Ratio 454.09
Div & Yield N.A. (N.A)

Latest News

Global Gloom: Cramer's 'Mad Money' Recap (Monday 6/18/18)

Global Gloom: Cramer's 'Mad Money' Recap (Monday 6/18/18)

Jim Cramer says we need stocks that are in sync with the global gloom and can be bought when we feel gloomy, which is pretty much every day.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: AKAM, ALB, DIOD, ECOM, EZPW, FRGI, GWRS, HIBB, HLX, LGND, MTCH, OIIM, PWOD Downgrades: BWINA, BWINB, GBL, ICUI, MOC, RCM, SINA, TPRE Initiations: ARA, FBM, PUMP Read on to get TheStreet Quant Ratings' detailed report:

ICU Medical, Inc. Announces Fourth Quarter And Fiscal Year 2017 Results

ICU Medical, Inc. Announces Fourth Quarter And Fiscal Year 2017 Results

Company Updates FY 2018 Adjusted EPS Guidance

Six Off the Beaten Path Healthcare Stock Gems

Six Off the Beaten Path Healthcare Stock Gems

These lesser-known diagnostic and life sciences firms are involved in areas from genetic tools to telemedicine.

ICU Medical, Inc. Announces Third Quarter 2017 Results

ICU Medical, Inc. Announces Third Quarter 2017 Results

Company Updates FY 2017 Guidance and Provides Initial FY 2018 EBITDA and Adjusted EPS Guidance

ICU Medical Completes The Acquisition Of Hospira Infusion Systems From Pfizer

The addition of Hospira's IV pumps, solutions, and devices business to ICU Medical's existing portfolio creates a leading pure-play infusion therapy company with focus and global scale

Drugmakers Plan Huge Deals in 2017 -- and Banks Will Collect Big Fees

Drugmakers Plan Huge Deals in 2017 -- and Banks Will Collect Big Fees

Here are the winning banks.

ICU Medical Wins Big Price Cut to Buy Pfizer's Hospira Unit

ICU Medical Wins Big Price Cut to Buy Pfizer's Hospira Unit

ICU Medical will pay $900 million for the infusion therapy unit rather than $1 billion.

These 5 Health Care Stocks Are Breaking Out This Christmas

These 5 Health Care Stocks Are Breaking Out This Christmas

The health care sector has been a miserable performer lately -- but these five health trades are bucking the trend.

Short Interest Increases 55.7% For ICUI

Short Interest Increases 55.7% For ICUI

The most recent short interest data has been released for the 10/31/2016 settlement date, which shows a 296,246 share increase in total short interest for ICU Medical, Inc. , to 828,440, an increase of 55.67% since 10/14/2016.

ICUI Crosses Above Average Analyst Target

ICUI Crosses Above Average Analyst Target

In recent trading, shares of ICU Medical, Inc. have crossed above the average analyst 12-month target price of $142.50, changing hands for $142.80/share.

TheStreet Quant Rating: C+ (Hold)